MedPath
FDA Approval

EPIDUO

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 21, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Adapalene(1 mg in 1 g)
Benzoyl peroxide(25 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

G Production Inc.

Galderma Laboratories, L.P.

251676961

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

EPIDUO

Product Details

NDC Product Code
0299-5908
Application Number
NDA022320
Marketing Category
NDA (C73594)
Route of Administration
TOPICAL
Effective Date
February 19, 2018
poloxamer 124Inactive
Code: 1S66E28KXAClass: IACT
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
AdapaleneActive
Code: 1L4806J2QFClass: ACTIBQuantity: 1 mg in 1 g
Code: W9WZN9A0GMClass: ACTIBQuantity: 25 mg in 1 g
glycerinInactive
Code: PDC6A3C0OXClass: IACT
docusate sodiumInactive
Code: F05Q2T2JA0Class: IACT
edetate disodiumInactive
Code: 7FLD91C86KClass: IACT
IsohexadecaneInactive
Code: 918X1OUF1EClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
Sorbitan MonooleateInactive
Code: 06XEA2VD56Class: IACT
© Copyright 2025. All Rights Reserved by MedPath